ID
11948
Description
MIPSO Vergleichende Untersuchung der bakteriellen Mikrobiota in der Haut sowie dem Darm von Psoriasis-Patienten vor und nach systemischer Behandlung mit Adalimumab bzw. Ustekinumab oder Ciclosporin (EudraCT 2014-003022-40) Principal Investigator: Prof. Dr. Dr. h.c. Thomas A. Luger
Keywords
Versions (4)
- 8/25/15 8/25/15 - Martin Dugas
- 8/26/15 8/26/15 - Martin Dugas
- 12/1/15 12/1/15 -
- 7/25/16 7/25/16 -
Uploaded on
August 25, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ciclosporin Psoriasis MIPSO EudraCT 2014-003022-40
Ciclosporin Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: SE
Description
Ciclosporin RQG
Description
Ciclosporin Startdatum
Data type
date
Description
Ciclosporin Startdatum Status
Data type
text
Description
Ciclosporin Enddatum
Data type
date
Description
Ciclosporin Enddatum Status
Data type
text
Description
Ciclosporin Dosis (mg)
Data type
integer
Description
Ciclosporin Intervall
Data type
text
Description
Ciclosporin Intervall Tage
Data type
integer
Similar models
Ciclosporin Psoriasis MIPSO EudraCT 2014-003022-40
- StudyEvent: SE